Cleared Traditional

K946170 - COMFORT-Q SUBCUTANEOUS INJECTION SETS

K946170 is an FDA 510(k) clearance for COMFORT-Q SUBCUTANEOUS INJECTION SETS, manufactured by B. Braun of America, Inc.. The device is a Class 2 General Hospital device with product code FOZ cleared through the Traditional 510(k) pathway after a 319-day FDA review.

K946170 · B. Braun of America, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1995
Decision
319d
Days
Class 2
Risk

K946170 is an FDA 510(k) clearance for the COMFORT-Q SUBCUTANEOUS INJECTION SETS. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by B. Braun of America, Inc. (Bethlehem, US). The FDA issued a Cleared decision on November 3, 1995 after a review of 319 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all B. Braun of America, Inc. devices

FDA 510(k) Submission Details - K946170

510(k) Number K946170 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 1994
Decision Date November 03, 1995
Days to Decision 319 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
190d slower than avg
Panel avg: 129d · This submission: 319d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FOZ Device Classification - Class 2, Special Controls

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 279
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K946170.
MICRO THERAPEUTICS VARIABLE INFUSION LENGTH CATHETER
K953335 · Micro Therapeutics, Inc. · Jan 1996
VITAL SIGNS SALINE VASCULAR ACCESS FLUSH DEVICE
K952645 · Vital Signs, Inc. · Dec 1995
VITAL SIGNS HEPARIN VASCULAR ACCESS FLUSH DEVICE
K953120 · Vital Signs, Inc. · Dec 1995
STERILE V.A.D. (VASCULAR ACCESS DEVICES) ACCESS KIT, DISPOSABLE
K952058 · Trinity Laboratories, Inc. · Sep 1995
BIONECTOR
K941678 · Vygon Corp. · Jun 1995
SIMS DELTEC, INC. CATHETER REPLACEMENT CONNECTOR
K950284 · Sims Deltec, Inc. · May 1995